Abeta induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597-624).

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Gideon M ShakedE H Koo

Abstract

Amyloid beta-peptide (Abeta) is postulated to play a central role in the pathogenesis of Alzheimer's disease. We recently proposed a pathway of Abeta-induced toxicity that is APP dependent and involves the facilitation of APP complex formation by Abeta. The APP-dependent component requires cleavage of APP at position 664 in the cytoplasmic domain, presumably by caspases or caspase-like proteases, with release of a potentially cytotoxic C31 peptide. In this study we show that Abeta interacted directly and specifically with membrane-bound APP to facilitate APP homo-oligomerization. Using chimeric APP molecules, this interaction was shown to take place between Abeta and its homologous sequence on APP. Consistent with this finding, we demonstrated that Abeta also facilitated the oligomerization of beta-secretase cleaved APP C-terminal fragment (C99). We found that the YENPTY domain in the APP cytoplasmic tail and contained within C31 is critical for this cell death pathway. Deletion or alanine- scanning mutagenesis through this domain significantly attenuated cell death apparently without affecting either APP dimerization or cleavage at position 664. This indicated that sequences within C31 are required after its release from APP. ...Continue Reading

References

Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·W WascoF Solomon
Oct 6, 1998·Annual Review of Biochemistry·F E Cohen, S B Prusiner
Aug 28, 1999·The Journal of Biological Chemistry·D M WalshD B Teplow
Jan 24, 2002·Neurobiology of Aging·William L Klein
Jul 11, 2002·The Journal of Biological Chemistry·William E Van NostrandFeng Xu
Jul 19, 2002·Journal of Neurochemistry·Veronica GalvanDale E Bredesen
Sep 14, 2002·The Journal of Biological Chemistry·Meir H ScheinfeldLuciano D'Adamio
Oct 26, 2002·Science·Dennis J Selkoe
Aug 19, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Hye-Sun KimYoo-Hun Suh
Oct 11, 2003·Journal of Neurochemistry·Daniel C LuEdward H Koo
Jul 21, 2004·Neurobiology of Disease·Lorena HerediaAlfredo Lorenzo
Nov 13, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Pascale N LacorWilliam L Klein
Dec 13, 2005·The Journal of Clinical Investigation·Yona LevitesTodd E Golde

❮ Previous
Next ❯

Citations

Sep 22, 2007·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Cristina CecchiGianfranco Liguri
Mar 11, 2010·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Mariagioia ZampagniCristina Cecchi
Apr 1, 2010·Acta Neuropathologica·Gunnar K GourasEstibaliz Capetillo-Zarate
Jul 15, 2009·The Journal of Biological Chemistry·Simone EggertEdward H Koo
Feb 7, 2009·The Journal of Biological Chemistry·Luca GilibertoMassimo Tabaton
Oct 30, 2008·The Journal of Biological Chemistry·Bruce A Yankner, Tao Lu
Nov 28, 2007·Annual Review of Pathology·Bruce A YanknerPatrick Loerch
Aug 7, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Davide TampelliniGunnar K Gouras
Jan 8, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Julie A HarrisLennart Mucke
Aug 3, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Roger LefortMichael Shelanski
Mar 31, 2009·International Journal of Molecular Sciences·Massimo Stefani
Feb 26, 2011·International Journal of Alzheimer's Disease·Amany Mohamed, Elena Posse de Chaves
Nov 6, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Gunnar K GourasOskar Hansson
Sep 10, 2008·Neurobiology of Disease·Christopher D LinkGretchen H Stein
Nov 23, 2006·Biochimica Et Biophysica Acta·Rachael L Neve, Donna L McPhie
Aug 15, 2009·Biochemical and Biophysical Research Communications·Sun Ah ParkEdward H Koo
Dec 9, 2008·Neurobiology of Aging·Susan A Austin, Colin K Combs
Jan 4, 2017·PloS One·Stefan RassStefan Schauer
Feb 16, 2017·Frontiers in Molecular Neuroscience·Nadia CanuPietro Calissano
Jun 15, 2013·International Journal of Molecular Sciences·Massimo Stefani, Stefania Rigacci
Apr 5, 2018·Acta Neuropathologica Communications·Alejandro Ruiz-RiquelmeJoel C Watts
Jun 12, 2013·Nature Communications·Julio PozuetaMichael Shelanski
May 1, 2007·The Journal of Biological Chemistry·Davide TampelliniGunnar K Gouras
Jan 16, 2008·Journal of Cellular and Molecular Medicine·C CecchiM Stefani
Jun 17, 2020·The Journal of Clinical Investigation·Daniela PuzzoOttavio Arancio
Jul 1, 2020·Journal of Alzheimer's Disease : JAD·Maria ChatzistavrakiSpiros Efthimiopoulos
Nov 30, 2011·Journal of Neurochemistry·Blaine R RobertsJames A Duce
Oct 16, 2013·Molecular Medicine Reports·Sanli XingZhihua Yu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.